Area of research
Oncology · Immunology
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers, and Cancer, Hypoxia, and Metabolism.
Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer
Tumour extracellular vesicles and particles induce liver metabolic dysfunction
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers
The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance
Cancer Manipulation of Host Physiology: Lessons from Pancreatic Cancer
The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression
γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation
TLR9 ligation in pancreatic stellate cells promotes tumorigenesis
Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury
Dectin-1 Regulates Hepatic Fibrosis and Hepatocarcinogenesis by Suppressing TLR4 Signaling Pathways
TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia
Pancreatic Cancer, Inflammation, and Microbiome
Interleukin 17–Producing γδT Cells Promote Hepatic Regeneration in Mice
Adoptive Immunotherapy of Epithelial Ovarian Cancer with Vγ9Vδ2 T Cells, Potentiated by Liposomal Alendronic Acid
Dendritic Cells Limit Fibroinflammatory Injury in Nonalcoholic Steatohepatitis in Mice
Role of Fatty-Acid Synthesis in Dendritic Cell Generation and Function
MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells
Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans
Dendritic Cell Populations With Different Concentrations of Lipid Regulate Tolerance and Immunity in Mouse and Human Liver